Novartis Seeks To Be Generics “Powerhouse” With Eon, Hexal Acquisitions

Novartis expects the addition of Eon Labs and Hexal AG to its Sandoz division to create a generic drug "powerhouse" that will play a major role in the emerging "authorized" generics and follow-on biologics markets